CVS Health Corporation (NYSE:CVS) EVP Helena Foulkes sold 39,340 shares of the company’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $81.88, for a total transaction of $3,221,159.20. Following the transaction, the executive vice president now owns 84,337 shares of the company’s stock, valued at approximately $6,905,513.56. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Helena Foulkes also recently made the following trade(s):
- On Monday, June 26th, Helena Foulkes sold 20,333 shares of CVS Health Corporation stock. The stock was sold at an average price of $80.00, for a total transaction of $1,626,640.00.
CVS Health Corporation (NYSE CVS) traded down 0.25% during midday trading on Tuesday, hitting $83.10. 4,568,000 shares of the company’s stock traded hands. The company has a market capitalization of $84.48 billion, a PE ratio of 16.55 and a beta of 0.92. The company has a 50 day moving average of $79.02 and a 200-day moving average of $78.96. CVS Health Corporation has a 52 week low of $69.30 and a 52 week high of $90.85.
CVS Health Corporation (NYSE:CVS) last issued its quarterly earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 EPS for the quarter, topping the consensus estimate of $1.31 by $0.02. The firm had revenue of $45.69 billion for the quarter, compared to analysts’ expectations of $45.36 billion. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. CVS Health Corporation’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period in the previous year, the business earned $1.32 earnings per share. Equities research analysts predict that CVS Health Corporation will post $5.88 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, November 3rd. Investors of record on Tuesday, October 24th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.41%. CVS Health Corporation’s dividend payout ratio is currently 39.92%.
COPYRIGHT VIOLATION WARNING: This news story was first published by Transcript Daily and is the property of of Transcript Daily. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States & international copyright and trademark law. The legal version of this news story can be accessed at https://transcriptdaily.com/2017/09/19/insider-selling-cvs-health-corporation-cvs-evp-sells-39340-shares-of-stock.html.
A number of equities analysts have recently weighed in on CVS shares. Vetr raised shares of CVS Health Corporation from a “buy” rating to a “strong-buy” rating and set a $87.97 price target on the stock in a research note on Wednesday, May 24th. BidaskClub cut shares of CVS Health Corporation from a “hold” rating to a “sell” rating in a research note on Friday, August 25th. Loop Capital started coverage on shares of CVS Health Corporation in a research note on Thursday, August 24th. They set a “hold” rating and a $83.00 price target on the stock. Guggenheim reaffirmed a “buy” rating on shares of CVS Health Corporation in a research note on Monday, July 3rd. Finally, Leerink Swann set a $90.00 price target on shares of CVS Health Corporation and gave the stock a “buy” rating in a research note on Tuesday, June 27th. One analyst has rated the stock with a sell rating, eight have given a hold rating and fifteen have assigned a buy rating to the company’s stock. CVS Health Corporation presently has a consensus rating of “Buy” and an average target price of $90.58.
A number of institutional investors and hedge funds have recently modified their holdings of CVS. FMR LLC increased its stake in CVS Health Corporation by 22.0% in the 2nd quarter. FMR LLC now owns 30,150,634 shares of the pharmacy operator’s stock worth $2,425,920,000 after purchasing an additional 5,446,930 shares in the last quarter. Boston Partners increased its stake in CVS Health Corporation by 69.1% in the 2nd quarter. Boston Partners now owns 6,459,237 shares of the pharmacy operator’s stock worth $519,711,000 after purchasing an additional 2,638,888 shares in the last quarter. Parametric Portfolio Associates LLC increased its stake in CVS Health Corporation by 71.5% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,949,854 shares of the pharmacy operator’s stock worth $317,805,000 after purchasing an additional 1,647,168 shares in the last quarter. LSV Asset Management increased its stake in CVS Health Corporation by 44.2% in the 1st quarter. LSV Asset Management now owns 4,579,916 shares of the pharmacy operator’s stock worth $359,523,000 after purchasing an additional 1,404,384 shares in the last quarter. Finally, Prudential Financial Inc. increased its stake in CVS Health Corporation by 61.8% in the 2nd quarter. Prudential Financial Inc. now owns 2,946,531 shares of the pharmacy operator’s stock worth $237,078,000 after purchasing an additional 1,125,400 shares in the last quarter. 81.49% of the stock is currently owned by hedge funds and other institutional investors.
About CVS Health Corporation
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.